An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
Clinical trial NCT01512420 · COMPLETED
Trial details
- NCT number
- NCT01512420
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-02-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.